Glycom receives Novel Food status for HMO blend
date:Dec 05, 2019
cluded analytical reports on the structure comparison of 2-FL and DFL, characterization data on the production bacterial strains and their certificates, specifications for raw materials, analytical methods and other reports. However, the EFSA notes that much of this data was crucial for determining the safety of 2-FL/DFL.

2-FL/DFL is obtained by microbial fermentation with a genetically modified strain of Escherichia coli strain K12 DH1. Currently, there are three HMOs available: Lacto-N-neotet
5/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/20 04:12